Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![MaisaCorp Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1370906497.png) MAISA [@MaisaCorp](/creator/twitter/MaisaCorp) on x 3118 followers
Created: 2025-07-14 13:04:58 UTC

$AMLX an analysis of a phase 2b clinical trial of a 90-milligram dose of its  investigational drug avexitide for the treatment of post-bariatric hypoglycemia  led to a XX% least-squares mean reduction versus baseline in certain types of  hypoglycemic events.


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944744933065465977/c:line.svg)

**Related Topics**
[events](/topic/events)
[$amlx](/topic/$amlx)

[Post Link](https://x.com/MaisaCorp/status/1944744933065465977)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

MaisaCorp Avatar MAISA @MaisaCorp on x 3118 followers Created: 2025-07-14 13:04:58 UTC

$AMLX an analysis of a phase 2b clinical trial of a 90-milligram dose of its investigational drug avexitide for the treatment of post-bariatric hypoglycemia led to a XX% least-squares mean reduction versus baseline in certain types of hypoglycemic events.

XXX engagements

Engagements Line Chart

Related Topics events $amlx

Post Link

post/tweet::1944744933065465977
/post/tweet::1944744933065465977